Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CME (CME)

CME Group Q2 2026 revenue rises to $1.7 billion; diluted EPS $2.88 vs $2.81

Positive Impact 3 of 5 earnings Written later

CME Group reported second-quarter 2026 results for the quarter ended June 30, 2026. Total revenue rose to $1.7 billion from $1.69 billion a year earlier, and diluted earnings per share were $2.88 versus $2.81, but GAAP operating income fell to $1.1 billion from $1.13 billion.

Key points

  • Total revenue was $1,706.2 million, up from $1,692.0 million in Q2 2025; clearing and transaction fees were $1,352.5 million.
  • Diluted EPS was $2.88 versus $2.81; adjusted diluted EPS was $2.99 versus $2.96.
  • Operating income was $1,107.1 million versus $1,129.3 million; adjusted operating income was $1,185.0 million versus $1,200.8 million.
  • As of June 30, 2026, cash was $2.3 billion and debt was $3.4 billion; the company repurchased $695 million of its common shares and paid about $468 million in dividends in the quarter.

The filing

CompanyCME (CME)
Form8-K, current report
Filed with the SECJul 22, 2026, 7:15 AM ET
Accession number0001156375-26-000042

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 22, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.